Metabolic barriers to immunotherapy in renal cell carcinoma.

被引：2
|
作者：
Beckermann, Katy
Siska, Peter
Mason, Frank
Rathmell, Kimryn
Rathmell, Jeffrey C.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Vanderbilt Univ, Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11560
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Immunotherapy for renal cell carcinoma
    Park, Dong Soo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2008, 51 (06): : 569 - 575
  • [22] Immunotherapy for Renal Cell Carcinoma
    Rosenblatt, Jacalyn
    McDermott, David F.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) : 793 - +
  • [23] Immunotherapy for Renal Cell Carcinoma
    Vano, Yann-Alexandre
    Simonaggio, Audrey
    Thibault, Constance
    Oudard, Stephane
    BULLETIN DU CANCER, 2018, 105 : S24 - S34
  • [24] Immunotherapy in renal cell carcinoma
    Heine, Annkristin
    Holderried, Tobias A. W.
    Brossart, Peter
    IMMUNOTHERAPY, 2009, 1 (01) : 97 - 107
  • [25] Immunotherapy of renal cell carcinoma
    Cécile Gouttefangeas
    Arnulf Stenzl
    Stefan Stevanović
    Hans-Georg Rammensee
    Cancer Immunology, Immunotherapy, 2007, 56 : 117 - 128
  • [26] Immunotherapy for Renal Cell Carcinoma
    Itsumi, Momoe
    Tatsugami, Katsunori
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2010,
  • [27] Immunotherapy in renal cell carcinoma
    Bukowski, RM
    ONCOLOGY-NEW YORK, 1999, 13 (06): : 801 - +
  • [28] Follicular thyroid carcinoma masquerading as renal cell carcinoma.
    Chelliah, A
    Schade, DS
    Burge, MR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S148 - S149
  • [29] Association of mitochondrial metabolic activity and immune pathways with disease stage in renal cell carcinoma.
    Gulati, Shuchi
    Shamsaei, Behrouz
    Vemuri, Bhargav
    Yang, Juechen
    Secic, Dina
    Bischoff, Megan
    Figueroa, Julio A. Landero
    Plas, David R.
    Cunningham, Tom
    Meller, Jarek
    Czyzyk-Krzeska, Maria F.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] A pooled analysis of the efficacy and safety of cabozantinib post immunotherapy in patients with advanced renal cell carcinoma.
    Oya, Mototsugu
    Tamada, Satoshi
    Tatsugami, Katsunori
    Nakaigawa, Noboru
    Osawa, Takahiro
    Kanayama, Hiro-Omi
    Kondoh, Chihiro
    Sassa, Naoto
    Nishimura, Kazuo
    Nozawa, Masahiro
    Masumori, Naoya
    Miyoshi, Yasuhide
    Kimura, Akiko
    Kuroda, Shingo
    Motzer, Robert J.
    Choueiri, Toni K.
    Tomita, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345